Fred Li
Fred brings more than 14 years of experience in the CRO industry, with a strong background in business development.
Fred brings more than 14 years of experience in the CRO industry, with a strong background in business development.
Avance Clinical today announced the acquisition of LumaBridge, a specialized U.S.-based clinical CRO with deep expertise in oncology trials.
Avance Clinical today announced the acquisition of LumaBridge, a specialized U.S.-based clinical CRO with deep expertise in oncology trials.
We’re delighted to announce that Avance Clinical will be exhibiting at this year’s ASCO Annual Meeting. Join us at booth #37153 to discover how we partner with innovative biotech companies.
We’re excited to announce that Avance Clinical will be exhibiting at the 2026 BIO International Convention in San Diego (June 22–25, 2026) - the must-attend global gathering for the biotech industry.
Avance Clinical is excited to announce our participation in SCOPE Summit 2026, one of the most influential gatherings in clinical operations, where leading innovators in biotech, pharma, CROs, and technology come together to share strategies shaping the future of global drug development.
Avance Clinical, a partner for biotechs providing global contract research organization services, has announced the launch of the Renal & Cardiometabolic Center of Excellence
Avance Clinical announced the launch of its Center of Excellence dedicated to central nervous system (CNS) disorders.
Start your early-phase studies in Australia to gain regulatory speed, scientific flexibility, and significant cost efficiencies — then seamlessly expand globally with the same expert team.
Marty Kraut Ph.D. brings 22 years of CRO project management and operations experience to Avance Clinical. After obtaining his doctorate in Clinical Psychology from the University of North Carolina at Chapel Hill, Marty spent several years in private practice specializing in the treatment of adult ...